Regenera Pharma Overview

  • Founded
  • 2008
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

Regenera Pharma General Information

Description

Operator of a clinical-stage pharmaceutical company intended to develop drugs and other related pharmaceutical products. The company's drugs are used to treat neurological damage caused by pathological conditions and regenerating damaged tissues, enabling patients to avail drugs for neurodegenerative diseases and chronic non-healing wounds, providing patients to restore neural function.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Einstein 18, Science Park
  • Ness-Ziona
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenera Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 20-Apr-2021 000.00 Completed Out of Business
5. Later Stage VC (Series B) 02-Jan-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Secondary Transaction - Private 00.000 Completed Generating Revenue
3. Later Stage VC 17-Feb-2015 00.000 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jan-2012 $400K $1.02M Completed Startup
1. Angel (individual) 01-Jan-2011 $625K $625K Completed Startup
To view Regenera Pharma’s complete valuation and funding history, request access »

Regenera Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Preferred B1 000,000 00.000000 00.00 00.00 00 00.00 00.00
Preferred B 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Preferred A1 1,412,071 $0.010000 $5.75 $5.75 1x $5.75 2.78%
Preferred A 1,412,071 $0.010000 $4.6 $4.6 1x $4.6 21.24%
To view Regenera Pharma’s complete cap table history, request access »

Regenera Pharma Patents

Regenera Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190209582-A1 Compositions comprising triterpenoids Granted 24-Sep-2015 000000000
US-10588911-B2 Compositions comprising triterpenoids Active 24-Sep-2015 0000000000
AU-2016327288-A1 Compositions comprising triterpenoids Abandoned 24-Sep-2015 000000000
US-20180264006-A1 Compositions comprising triterpenoids Granted 24-Sep-2015 000000000
US-10285996-B2 Compositions comprising triterpenoids Active 24-Sep-2015 A61K31/56
To view Regenera Pharma’s complete patent history, request access »

Regenera Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial